Latest Shareholder Confidence News

WA Kaolin has launched its retail entitlement offer following the distribution of its prospectus, inviting eligible shareholders to participate in a key capital raising initiative.

Treasury Wine Estates has announced a 20-cent per share dividend for the half-year ending December 2024, accompanied by a fully franked component and an active Dividend Reinvestment Plan.

VGI Partners Global Investments reported a steep $43.1 million loss for the half-year ending December 2024 but announced an increased fully franked interim dividend and expanded share buy-back program.

PM Capital Global Opportunities Fund Limited has announced a fully franked ordinary dividend of AUD 0.055 per security for the half-year ending December 2024, offering shareholders a Dividend Reinvestment Plan option.

RLF AgTech Ltd has successfully raised approximately $2.42 million through an Entitlement Issue and Shortfall Placement, reflecting strong shareholder confidence in its turnaround strategy and growth prospects in Australia and Asia.

ikeGPS has halted acquisition talks after a private equity offer at a 62% premium failed to secure key shareholder backing, signaling confidence in its growth trajectory within the electric utility software market.

Spheria Emerging Companies Limited has announced a fully franked ordinary dividend of AUD 0.035 per share for the quarter ending December 2024, alongside an updated Dividend Reinvestment Plan pricing methodology.

Evion Group has successfully raised $1.33 million through a rights issue, positioning itself to accelerate production at its Panthera JV in India. The company also announced a bonus options offer to reward shareholders and support future expansion.

Sigma Healthcare has received Federal Court approval for its acquisition of Chemist Warehouse, marking a pivotal step in its strategic expansion. The scheme is set to become legally effective on February 4, 2025, with implementation expected by February 12.

Nex Metals Explorations Ltd reports steady progress on its Kookynie Gold Tailings Project and updates on Yundamindra drilling results, supported by a robust funding position.

Cleo Diagnostics reports steady progress in its U.S. and Australian clinical trials for an ovarian cancer blood test, maintaining a solid cash reserve of A$7.3 million as it prepares for FDA submission.

HITIQ Limited’s largest shareholder, Harmil Angel Investments, is converting $1.6 million in convertible notes into shares, while the company revamps its advisory mandate to attract US investors.